Insider · CIK 0001828246
Jun Wang
Files at YBGJ (Yubo International Biotech Ltd). First filing -, latest -.
In brief
Jun Wang files SEC Form 4 as president, director and 10% owner at YBGJ (Yubo International Biotech Ltd). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Jun Wang has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 23, 2025 | YBGJ Yubo International Biotech Ltd | AGrant or award Class A Common Stockindirect: Controlling Person of Entity | +42,000,000 | $0.05 | $2.1M | 81,943,800 | Jul 25, 2025 |
Questions about Jun Wang
Answered from the filings on this page, as of the latest one.
Is Jun Wang buying or selling?
Jun Wang has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Jun Wang's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jun Wang has 0.
Where does Jun Wang file Form 4?
Jun Wang has filed Form 4 at YBGJ (Yubo International Biotech Ltd) as President. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.